- Benzinga•21 hours ago
Leerink’s Michael Schmidt noted that despite the recent outperformance, Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA ) shares were still trading at a discount to its commercial-stage oncology biotech peers, ...
- optionMONSTER•4 days ago
At least one trader apparently sees little downside risk in Ariad Pharmaceuticals. optionMONSTER's tracking programs detected the sale of 2,000 November 13 puts in one print for $0.90 yesterday. This is ...
Ariad Pharmaceuticals Inc. (ARIA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||14.00 x 200|
|Ask||14.47 x 700|
|Day's Range||13.61 - 14.01|
|52wk Range||4.37 - 14.01|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-44.74|
|Avg Vol (3m)||5,330,156|
|Dividend & Yield||N/A (N/A)|